Because NFL generally is late biomarker in the disease process and a non–AD specific biomarker for axonal degeneration,15 the poor result could be because most of the participants (513 of 842) were cognitively unimpaired and only 64 had AD dementia. This evidence concerns the gene NEFL and Alzheimer disease.